Market revenue in 2023 | USD 362.7 million |
Market revenue in 2030 | USD 1,369.5 million |
Growth rate | 20.9% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 49.32% in 2023. Horizon Databook has segmented the France dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of France DNA sequencing market can primarily be attributed to extensive government initiatives that are boosting the adoption of NGS solutions in the country. Since 2013, the French National Cancer Institute (INCa) has supported the implementation of targeted NGS as part of routine clinical practice.
In addition, France implemented a national plan, the 2025 France Genomic Medicine Initiative, to ensure adequate access to genomic medicine for all patients. This initiative is dedicated to introducing genome sequencing to the care pathway.
In February 2020, Scipio Bioscience, a French startup, raised around USD 6.8 million (EUR 6 million) in Series A round for development of cost-effective single-cell RNA sequencing kits. These cost-effective tests have shown high potential in profiling cells for research and clinical diagnostics.
Horizon Databook provides a detailed overview of country-level data and insights on the France dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into France dna sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account